SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ionis Pharmaceuticals (IONS)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
4676 121 0 IONS
Emcee:  Keith Fauci Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3576Side effects are one of the main reasons imo that people don't take medicatiMJ-8/23/2004
3575Not yet. This is all I've seen, from an '02 PR: >>In the study, tuck-8/23/2004
3574They talk about the side effects of the statins. How about the side effect of tMJ-8/21/2004
3573Nevermind . . .looks like Mr. Market has noticed us now. : )The Band Leader-8/18/2004
3572OK you see it as being big, I see it as being big, but Mr Market sees it and yawThe Band Leader-8/12/2004
3571New Drug Uses Gene Method to Cut Cholesterol-Maker Wed Aug 11, 2004 06:07 PM ET bob zagorin-8/12/2004
3570my 2c - this is a big deal. 1. cardiovascular / cholesterol market is huge 2. sbob zagorin-8/11/2004
3569Second-Generation Antisense Drug for Cardiovascular Disease Demonstrates Signifibob zagorin-8/11/2004
3568Thanks, Tuck. EOM. ThomasThomas-8/11/2004
3567Suggest you check out the post I was responding to: Message 20098639 Reckon thtuck-8/10/2004
3566Hi Tuck, That is interesting and the Nature article sounds promising. Can you dThomas-8/10/2004
3565Survivin program with Lilly . . . This recent Nature Reviews freebie talks otuck-8/9/2004
3564from the new 10Q "...Overview Since our inception in 1989, we have pionebob zagorin-8/6/2004
3563Roth Cap. retiterates Buy today. they were on call yesterday and if i remember rbob zagorin-8/6/2004
3562Isis Pharmaceuticals Reports Second Quarter 2004 Financial Results and Highlightbob zagorin-8/5/2004
3561Webcast Alert: Isis Pharmaceuticals, Inc. Presentation at Informed Investors Secbob zagorin-7/26/2004
3560Promising Applications Support Global Uptake of RNAi Technology LONDON--(BUSINEbob zagorin-7/26/2004
3559Alnylam Pharmaceuticals (ALNY) To Webcast Presentation At Banc of America Securibob zagorin-7/23/2004
3558Note: the role of Resistin is controversial and complicated. Rat models and humtuck-7/15/2004
3557[Resistin Program for Diabetes -- Preclinical Studies] >>Published Onlinetuck-7/15/2004
3556Chairman's Quarterly Review July 9, 2004 Dear Isis Friends, Supporters andbob zagorin-7/13/2004
3555Alnylam gets new coverage with a buy rating from Piper Jaffrey today.bob zagorin-7/12/2004
3554i got this on another thread but maybe this guy was thinking of the stock not thbob zagorin-7/12/2004
3553ISIS will present Annual Metabolic Diseases Drug Discovery Conference to Take Pbob zagorin-7/8/2004
3552anyone have a comment on how this affects the ISIS-Alnylam alliance? I'm guebob zagorin-6/30/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News